NCT02278523

Brief Summary

Background:Respiratory muscle weakness is observed in chronic obstructive pulmonary disease(COPD) patients and contributes to hypercapnia, dyspnoea, nocturnal oxygen desaturation and reduced walking distance.During exercise it has been shown that diaphragm work is increased in COPD and COPD patients use a larger proportion of the maximal inspiratory pressure (MIP) than healthy subjects. This pattern of breathing is closely related to the dyspnoea sensation during exercise and might potentially induce respiratory muscle fatigue. Inspiratory muscle training(IMT) increases inspiratory muscle strength and endurance, and decreases dyspnoea.But the mechanism of IMT still lack of research. Purpose:The experiment is aim to compare of the similarities and differences of transdiaphragmatic pressure by detecting the transdiaphragmatic pressure of COPD patients and healthy volunteers in different intensity of threshold load conditions. Thus investigate how inspiratory muscle training works or mechanism in lung rehabilitation programmes of COPD.And emerging the theoretical basis of inspiratory muscle training from respiratory physiological mechanism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for phase_2 chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Jun 2014

Shorter than P25 for phase_2 chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2014

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 30, 2014

Completed
Last Updated

October 30, 2014

Status Verified

October 1, 2014

Enrollment Period

4 months

First QC Date

October 15, 2014

Last Update Submit

October 28, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Transdiaphragmatic pressure

    measure the transdiaphragmatic pressure while spontaneous breathing

    half an hour

Study Arms (2)

Inspiratory muscle training group

EXPERIMENTAL

COPD patient use Inspiratory muscle trainer (Threshold IMT®)

Device: Threshold IMT®

control group

ACTIVE COMPARATOR

normal volunteers use Inspiratory muscle trainer(Threshold IMT®)

Device: Threshold IMT®

Interventions

A device used to offer threshold load to inspiratory muscle

Also known as: threshold inspiratory muscle trainer
Inspiratory muscle training groupcontrol group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Severe and very severe COPD (postbronchodilator FEV1/FVC under 70% and FEV1 under 50% of the predicted value
  • Inspiratory muscle weakness(Maximal Inspiratory Pressure under 60cmH2O.
  • Bronchial dilation test(BDT) negative.

You may not qualify if:

  • Suffer from acute exacerbation less than 4 weeks.
  • Intravenous or oral corticosteroids in 4 weeks.
  • With other heart, lung and brain disorders.
  • With poor compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Respiratory muscle training device

Guangzhou, Guangdong, 510000, China

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Chen Rongchang, Master

    Guangzhou Institude of Respiratory Disease

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Guangzhou Institute of Respiratory Disease

Study Record Dates

First Submitted

October 15, 2014

First Posted

October 30, 2014

Study Start

June 1, 2014

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

October 30, 2014

Record last verified: 2014-10

Locations